Baxdela™ (delafloxacin) – New drug approval
June 19, 2017 – Melinta Therapeutics announced the FDA approval of Baxdela (delafloxacin) tablets and injection for the treatment of acute bacterial skin and skin structure infections (ABSSSI) caused by certain susceptible bacteria in adults.
Download PDF
